Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$3.16 - $4.96 $10,023 - $15,733
3,172 New
3,172 $13,000
Q4 2022

Jun 14, 2023

BUY
$5.03 - $8.58 $17,036 - $29,060
3,387 New
3,387 $19.6 Million
Q4 2022

Mar 30, 2023

BUY
$5.03 - $8.58 $2,902 - $4,950
577 Added 20.53%
3,387 $19,000
Q4 2022

Feb 15, 2023

BUY
$5.03 - $8.58 $2,902 - $4,950
577 Added 20.53%
3,387 $19,000
Q3 2022

Jun 14, 2023

BUY
$7.7 - $13.31 $21,637 - $37,401
2,810 New
2,810 $21.7 Million
Q2 2022

Jun 20, 2023

BUY
$6.72 - $16.07 $18,883 - $45,156
2,810 New
2,810 $25,000
Q1 2022

Jun 20, 2023

BUY
$11.88 - $23.4 $33,382 - $65,754
2,810 New
2,810 $42,000
Q1 2022

Mar 30, 2023

SELL
$11.88 - $23.4 $101,977 - $200,865
-8,584 Reduced 75.34%
2,810 $42,000
Q1 2022

May 12, 2022

SELL
$11.88 - $23.4 $101,977 - $200,865
-8,584 Reduced 75.34%
2,810 $43,000
Q4 2021

Jun 21, 2023

BUY
$21.08 - $38.51 $240,185 - $438,782
11,394 New
11,394 $259,000
Q3 2021

Jun 21, 2023

BUY
$27.67 - $45.04 $315,271 - $513,185
11,394 New
11,394 $393,000
Q3 2021

Mar 30, 2023

BUY
$27.67 - $45.04 $171,470 - $279,112
6,197 Added 119.24%
11,394 $393,000
Q3 2021

Nov 15, 2021

BUY
$27.67 - $45.04 $171,470 - $279,112
6,197 Added 119.24%
11,394 $393,000
Q2 2021

Mar 30, 2023

BUY
$28.75 - $56.92 $15,467 - $30,622
538 Added 11.55%
5,197 $170,000
Q2 2021

Aug 16, 2021

BUY
$28.75 - $56.92 $149,270 - $295,528
5,192 Added 103840.0%
5,197 $170,000
Q1 2021

Jun 26, 2023

BUY
$38.67 - $84.06 $180,163 - $391,635
4,659 New
4,659 $233 Million
Q1 2021

Mar 30, 2023

BUY
$38.67 - $84.06 $49,188 - $106,924
1,272 Added 37.56%
4,659 $233,000
Q1 2021

May 14, 2021

BUY
$38.67 - $84.06 $193 - $420
5 New
5 $233,000

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $98.4M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.